Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Behavior × Cannabidiol × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 3 Colonic Neoplasms 3 Breast Neoplasms 3 Sturge-Weber Syndrome 2 Seizures 2 Nausea 2 Marijuana Abuse 2 Glioblastoma 2 Anxiety Disorders 2 Vomiting 1 Solid Tumor 1 Rectal Neoplasms 1 Parasomnias 1 Pancreatic Neoplasms 1 Pain 1 Neoplasms 1 Multiple Myeloma 1 Liver Neoplasms 1 Liver Cirrhosis 1 Lennox Gastaut Syndrome 1 Gallbladder Neoplasms 1 Epilepsies, Myoclonic 1 Dysgeusia 1 Drug Resistant Epilepsy 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Cancer Pain 1

Interventions

Counseling 3 Motivational Interviewing 2 College Fraternities and Sororities 2 Transportation 1 Spermine Synthase 1 Risk Factors 1 Risk Assessment 1 Riluzole 1 Price Transparency 1 Precision Medicine 1 Palliative Care 1 Methods 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 House Calls 1 Exercise 1 Ethanol 1 Educational Status 1 Decision Support Techniques 1 Cannabidiol 1 Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05864846 2026-03-12

EpiCom

Jazz Pharmaceuticals

Phase 4 Active not recruiting

Behavior, Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡